1. Home
  2. PCVX vs NCLH Comparison

PCVX vs NCLH Comparison

Compare PCVX & NCLH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PCVX
  • NCLH
  • Stock Information
  • Founded
  • PCVX 2013
  • NCLH 1966
  • Country
  • PCVX United States
  • NCLH United States
  • Employees
  • PCVX N/A
  • NCLH N/A
  • Industry
  • PCVX Biotechnology: Pharmaceutical Preparations
  • NCLH Marine Transportation
  • Sector
  • PCVX Health Care
  • NCLH Consumer Discretionary
  • Exchange
  • PCVX Nasdaq
  • NCLH Nasdaq
  • Market Cap
  • PCVX 11.5B
  • NCLH 12.1B
  • IPO Year
  • PCVX 2020
  • NCLH 2013
  • Fundamental
  • Price
  • PCVX $79.74
  • NCLH $24.11
  • Analyst Decision
  • PCVX Strong Buy
  • NCLH Buy
  • Analyst Count
  • PCVX 8
  • NCLH 17
  • Target Price
  • PCVX $127.71
  • NCLH $29.06
  • AVG Volume (30 Days)
  • PCVX 881.2K
  • NCLH 9.3M
  • Earning Date
  • PCVX 02-25-2025
  • NCLH 02-27-2025
  • Dividend Yield
  • PCVX N/A
  • NCLH N/A
  • EPS Growth
  • PCVX N/A
  • NCLH N/A
  • EPS
  • PCVX N/A
  • NCLH 1.25
  • Revenue
  • PCVX N/A
  • NCLH $9,356,741,000.00
  • Revenue This Year
  • PCVX N/A
  • NCLH $13.12
  • Revenue Next Year
  • PCVX N/A
  • NCLH $8.07
  • P/E Ratio
  • PCVX N/A
  • NCLH $19.26
  • Revenue Growth
  • PCVX N/A
  • NCLH 15.76
  • 52 Week Low
  • PCVX $58.10
  • NCLH $14.69
  • 52 Week High
  • PCVX $121.06
  • NCLH $29.29
  • Technical
  • Relative Strength Index (RSI)
  • PCVX 36.96
  • NCLH 33.14
  • Support Level
  • PCVX $82.03
  • NCLH $25.53
  • Resistance Level
  • PCVX $84.10
  • NCLH $27.41
  • Average True Range (ATR)
  • PCVX 3.12
  • NCLH 1.09
  • MACD
  • PCVX -0.70
  • NCLH -0.31
  • Stochastic Oscillator
  • PCVX 1.88
  • NCLH 5.23

About PCVX Vaxcyte Inc.

Vaxcyte Inc is a vaccine company seeking to improve global health by developing novel vaccines to treat patients suffering from the most common and deadly diseases. Its product comprises. of Pneumococcal conjugate vaccine. The firm's product candidate consists of VAX-24, VAX-A1, and VAX-PG.

About NCLH Norwegian Cruise Line Holdings Ltd.

Norwegian Cruise Line is the world's third-largest publicly traded cruise company by berths (around 66,500). It operates 32 ships across three brands—Norwegian, Oceania, and Regent Seven Seas—offering both freestyle and luxury cruising. The company redeployed its entire fleet as of May 2022. With 13 passenger vessels on order among its brands through 2036, representing 41,000 incremental berths, Norwegian is increasing capacity faster than its peers, expanding its brand globally. Norwegian sails to around 700 global destinations.

Share on Social Networks: